35MO Discovery and characterization of selective, FGFR1-sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers
Titel:
35MO Discovery and characterization of selective, FGFR1-sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers
Auteur:
Dardenne, E. Padilla, F. Rasmussen, S. Yang, S.N. Mentes, A. Ogawa, L.S. Fiorenza, R. Trombino, A. Smith, S. Romashko, D. Ishiyama, N. Chevtsova, M. Thakur, S. Rosfjord, E. Buck, E. Roberts, C. Lucas, M. Lin, T-A.